Lemaitre Vascular (LMAT) EPS (Basic) (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of EPS (Basic) data on file, last reported at $0.69 in Q1 2026.

• EPS (Basic) for Q1 2026 came in at $0.69, up 40.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.76 (up 36.63% YoY), and the FY2025 annual result was $2.55, up 30.1% from the prior year.
• EPS (Basic) steadied at $0.69 in Q1 2026 per LMAT's latest filing, from $0.69 in the prior quarter.
• Over five years, EPS (Basic) peaked at $0.77 in Q3 2025 and troughed at $0.16 in Q2 2022.
• A 5-year average of $0.44 and a median of $0.44 in 2024 frame the typical range for EPS (Basic).
• The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 60.0% in 2022, then surged 125.0% in 2023.
• A 5-year view of EPS (Basic) shows it stood at $0.26 in 2022, then soared by 46.15% to $0.38 in 2023, then surged by 31.58% to $0.5 in 2024, then surged by 38.0% to $0.69 in 2025, then gained by 0.0% to $0.69 in 2026.
• Business Quant data shows LMAT's EPS (Basic) at $0.69 in Q1 2026, $0.69 in Q4 2025, and $0.77 in Q3 2025.